Michelle Zhang

Company: Ikena Oncology

Job title: Chief Scientific Officer

Seminars:

Targeting MEK-RAF Complex to Overcome CRAF Mediated Resistance & Drive Superior Anti-Tumor Activity in RAS/RAF Altered Cancers 2:15 pm

Showcasing how trapping MEK-RAF in an inactive complex blocks CRAF mediated MEK reactivation that limits the efficacy of approved MEK inhibitors in RAS mutant tumors Examining how more complete MAPK pathway inhibition results in potent anti-tumor activity across a broad range of RAS/RAF altered cancer cell lines/models Understanding how intermittent dosing schedules that enable transient…Read more

day: Day 2 Track A PM